Association study of three single-nucleotide polymorphisms in the cyclic adenosine monophosphate response element binding 1 gene and major depressive disorder

Experimental and Therapeutic Medicine

Volumn 9, Issue 6, 2015, Pages 2235-2240

  Wei, Yange ^a,b   Bu, Shufang ^b   Liu, Xican ^b   Li, Hengfen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cyclic adenosine monophosphate response element binding protein 1; Gene; Major depressive disorder; Single nucleotide polymorphism

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DSM-IV; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GENOTYPING TECHNIQUE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84928239224     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2408     Document Type: Article

References (34)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT and Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757, 2006.
2. Spiessl H, Hübner-Liebermann B and Hajak G: Depression, a widespread disease. Epidemiology, care situation, diagnosis, therapy and prevention. Dtsch Med Wochenschr 131: 35-40, 2006 (In German).
3. Mamdani F, Alda M, Grof P, Young LT, Rouleau G and Turecki G: Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet 147B: 500-504, 2008.
4. Risch N, Herrell R, Lehner T, et al: Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301: 2462-2471, 2009.
5. Kendler KS, Gatz M, Gardner CO and Pedersen NL: Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiatry 63: 1113-1120, 2006.
6. Terracciano A, Tanaka T, Sutin AR, et al: Genome-wide association scan of trait depression. Biol Psychiatry 68: 811-817, 2010.
7. Cryan JF and Mombereau C: In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9: 326-357, 2004.
8. Gaspar L, van de Werken M, Johansson AS, Moriggi E, Owe-Larsson B, Kocks JW, Lundkvist GB, Gordijn MC and Brown SA. Human cellular differences in cAMP--CREB signaling correlate with light-dependent melatonin suppression and bipolar disorder. Eur J Neurosci 40: 2206-2215, 2014.
9. Meyer J, Wiedemann P, Okladnova O, et al: Cloning and functional characterization of the human norepinephrine transporter gene promoter. J Neural Transm 105: 1341-1350, 1998.
10. Zhang HT, Whisler LR, Huang Y, Xiang Y and O'Donnell JM: Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior. Neuropsychopharmacology 34: 1067-1077, 2009.
11. Hu YF, Caron MG and Sieber-Blum M: Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis. BMC Genomics 10: 151, 2009.
12. Brummett BH, Babyak MA, Williams RB, Harris KM, Jiang R, Kraus WE, Singh A,Costa PT, Georgiades A and Siegler IC: A Putatively Functional Polymorphism in the HTR2C Gene is Associated with Depressive Symptoms in White Females Reporting Significant Life Stress. PLoS One 9: e114451, 2014.
13. Fabbri C, Souery D, Calati R, et al: Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients. J Neural Transm 122: 43-58, 2015.
14. Li M, Luo XJ, Rietschel M, et al: Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. Mol Psychiatry. 19: 452-461, 2014.
15. Calati R, Crisafulli C, Balestri M, et al: Evaluation of the role of MAPK1 and CREB1polymorphisms on treatment resistance, response and remission in mood disorder patients. Prog Neuropsychopharmacol Biol Psychiatry. 1;44:271-278, 2013.
16. Bae JS, Kim JY, Park BL, et al: Investigating the potential genetic association between RANBP9 polymorphisms and the risk ofschizophrenia. Mol Med Rep Dec 4, 2014 (Epub ahead of print). doi: 10.3892/mmr.2014.3045.
17. Zhong X, Zhang L, Han S, An Z and Yi Q: Case control study of association between the ANK3 rs10761482 polymorphism and schizophrenia in persons of Uyghur nationality living in Xinjiang China. Shanghai Arch Psychiatry 26: 288-293, 2003.
18. Jitoku D, Yamamoto N, Iwayama Y, et al: Association study of H2AFZ with schizophrenia in a Japanese case-control sample. J Neural Transm. Nov 13, 2014 (Epub ahead of print).
19. Oelke M, Hedlund P, Albrecht K, et al: Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology 67: 1111-1116, 2006.
20. Liu XH: Preliminary study on the genetic effects and genetic mode of first-episode depression, as well as association and expression study of CREB1, BDNF gene in major depression. Unpublished PhD thesis. Fudan University, Shanghai, 2006 (In Chinese).
21. Liu XH, Xu YF, Cui DH, et al: Association of cyclic adenosine monophosphate response element-binding protein gene and major depressive disorder. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27: 263-266, 2010 (In Chinese).
22. Turner CA, Thompson RC, Bunney WE, et al: Altered choroid plexus gene expression in major depressive disorder. Front Hum Neurosci 8: 238, 2014.
23. Li M, Luo XJ, Rietschel M, et al: MooDS Bipolar Consortium, Swedish Bipolar Study Group, Alzheimer's Disease Neuroimaging Initiative, ENIGMA Consortium and CHARGE Consortium: Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. Mol Psychiatry 19: 452-461, 2014.
24. Lipina TV, Fletcher PJ, Lee FH, Wong AH and Roder JC: Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β -arrestin-1,2 in the nucleus accumbens in a mouse model of depression. Neuropsychopharmacology 38: 423-436, 2013.
25. Wang H, Zhang Y and Qiao M: Mechanisms of extracellular signal-regulated kinase/cAMP response element-binding protein/brain-derived neurotrophic factor signal transduction pathway in depressive disorder. Neural Regen Res 8: 843-852, 2013.
26. Serretti A, Chiesa A, Calati R, et al: A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. J Affect Disord 128: 56-63, 2011.
27. Burcescu I, Wigg K, King N, et al: Association study of CREB1 and childhood-onset mood disorders. Am J Med Genet B Neuropsychiatr Genet 137B: 45-50, 2005.
28. Calati R, Crisafulli C, Balestri M, et al: Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 44: 271-278, 2013.
29. Martini C, Da Pozzo E, Carmassi C, et al: Cyclic adenosine monophosphate responsive element binding protein in post-traumatic stress disorder. World J Biol Psychiatry 14: 396-402, 2013.
30. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS and Young LTG: Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 73: 1121-1126, 1999.
31. Yamada S, Yamamoto M, Ozawa H, Riederer P and Saito T: Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J Neural Transm 110: 671-680,2003
32. Koch JM, Hinze-Selch D, Stingele K, et al: Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression. Psychother Psychosom 78: 187-192, 2009.
33. Blendy JA. The role of CREB in depression and antidepressant treatment. Biol Psychiatry 59: 1144-1150, 2006.
34. Qi X, Lin W, Li J, Li H, Wang W, Wang D and Sun M: Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol Dis 31: 278-285, 2008.